A detailed history of Franklin Resources Inc transactions in Novo Cure LTD stock. As of the latest transaction made, Franklin Resources Inc holds 56,060 shares of NVCR stock, worth $1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
56,060
Previous 56,515 0.81%
Holding current value
$1 Million
Previous $883,000 8.72%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$11.83 - $24.05 $5,382 - $10,942
-455 Reduced 0.81%
56,060 $960,000
Q1 2024

May 13, 2024

BUY
$12.42 - $17.29 $27,572 - $38,383
2,220 Added 4.09%
56,515 $883,000
Q4 2023

Feb 09, 2024

BUY
$11.13 - $15.78 $604,303 - $856,775
54,295 New
54,295 $810,000
Q2 2023

Aug 11, 2023

BUY
$40.29 - $82.51 $43,634 - $89,358
1,083 Added 18.61%
6,902 $286,000
Q1 2023

May 12, 2023

SELL
$56.44 - $118.81 $78,451 - $165,145
-1,390 Reduced 19.28%
5,819 $349,000
Q4 2022

Feb 10, 2023

BUY
$63.98 - $85.37 $58,157 - $77,601
909 Added 14.43%
7,209 $528,000
Q3 2022

Nov 14, 2022

BUY
$67.99 - $89.57 $77,168 - $101,661
1,135 Added 21.97%
6,300 $478,000
Q2 2022

Aug 11, 2022

BUY
$56.6 - $89.9 $17,659 - $28,048
312 Added 6.43%
5,165 $360,000
Q1 2022

May 13, 2022

BUY
$60.15 - $84.52 $51,187 - $71,926
851 Added 21.26%
4,853 $402,000
Q4 2021

Feb 11, 2022

SELL
$75.08 - $121.99 $41,369 - $67,216
-551 Reduced 12.1%
4,002 $301,000
Q3 2021

Nov 12, 2021

SELL
$116.17 - $194.55 $83,410 - $139,686
-718 Reduced 13.62%
4,553 $528,000
Q2 2021

Aug 13, 2021

SELL
$130.4 - $225.58 $500,996 - $866,678
-3,842 Reduced 42.16%
5,271 $1.17 Million
Q1 2021

May 13, 2021

SELL
$124.11 - $190.17 $11.7 Million - $18 Million
-94,496 Reduced 91.2%
9,113 $1.21 Million
Q4 2020

Feb 10, 2021

BUY
$112.16 - $174.14 $11.4 Million - $17.7 Million
101,504 Added 4822.04%
103,609 $17.9 Million
Q3 2020

Nov 12, 2020

BUY
$58.05 - $111.31 $122,195 - $234,307
2,105 New
2,105 $234,000

Others Institutions Holding NVCR

About NovoCure Ltd


  • Ticker NVCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 104,950,000
  • Market Cap $1.87B
  • Description
  • NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...
More about NVCR
Track This Portfolio

Track Franklin Resources Inc Portfolio

Follow Franklin Resources Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.